Sea Pharmaceuticals, LLC — SEC Form D Filing
Sea Pharmaceuticals, LLC filed an SEC Form D on May 20, 2026, reporting $71K raised in Pharmaceuticals.
Form D filing details
- Filing
- SEC Form D
- Filing date
- May 20, 2026
- Amount reported
- $71K
- Industry
- Pharmaceuticals
- Website
- https://www.seapharmaceuticals.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: IOWA
Problem
There is a need for effective treatments for Tinnitus, Epilepsy, and Sporadic ALS.
Solution
Sea Pharmaceuticals is developing proprietary synthetic small molecule treatments for Tinnitus, Epilepsy, and Sporadic ALS.
Verdict
Investors were likely persuaded to invest in Sea Pharmaceuticals due to the pressing need for effective treatments for Tinnitus, Epilepsy, and Sporadic ALS, which positioned the company at the intersection of high unmet medical needs. This cleared because the narrative centered around addressing significant health issues, not because of established advantage or market presence. However, the limited upside lies in the fact that without a clear plan to differentiate from competitors developing similar treatments, the long-term viability of the investment remains uncertain.
Source: SEC EDGAR Form D filing